N
688273
vs
S
Shanghai Composite
Over the past 12 months, Nanjing Medlander Medical Technology Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +83% compared to the Shanghai Composite's +23% growth.
Stocks Performance
688273 vs Shanghai Composite
Performance Gap
688273 vs Shanghai Composite
Performance By Year
688273 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Nanjing Medlander Medical Technology Co Ltd
Glance View
Nanjing Medlander Medical Technology Co., Ltd. engages in the research, development, production, and sale of pelvic floor rehabilitation products. The company is headquartered in Nanjing, Jiangsu and currently employs 511 full-time employees. The company went IPO on 2022-08-11. The firm's products mainly include pelvic floor and postpartum rehabilitation equipment, consumables and accessories, information products and others, including biostimulation feedback instruments, basin training instruments, basin biostimulation feedback instruments, vaginal electrodes, pelvic maintenance instruments and others. The firm's products are mainly used in obstetrics and gynecology, gynecology, pelvic floor rehabilitation centers, confinement centers, postpartum rehabilitation centers, mother and child centers and other professional institutions in medical institutions.
